Sign up to save your podcasts
Or
Share touchPODCAST
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
touchPODCAST
By touchpodcastScience
touchPODCAST episodes
- Support structures for adolescents with SMA transitioning to the adult healthcare system
touchMDT for touchNEUROLOGY
Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
15 min - Later-onset SMA: Presentation and differential diagnosis
touchMDT for touchNEUROLOGY
Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Neurologist: Dr James Wymer, Gainesville, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
14 min - Multidisciplinary care and quality of life of adolescents/adults with SMA
touchMDT for touchRESPIRATORY
Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
- Patient: Mr Jim Willison, Sheffield, OH, USA
- Physical Therapist: Dr Lisa Fukuzato, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/
14 min - Support structures for adolescents with SMA transitioning to the adult healthcare system
touchMDT for touchRESPIRATORY
Listen to an SMA specialist discuss with a young adult with SMA type 3 the transition of adolescent patients into adult healthcare services
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Patient: Mr Hugo Trevino, Chicago, IL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratory.com/cme/later-onset-SMA-quality-of-life/
15 min - Later-onset SMA: Presentation and differential diagnosis
touchMDT for touchNEUROLOGY
Listen to an SMA expert and a neurologist discuss the clinical presentation of later-onset SMA in adolescents and adults, and the processes for differential diagnosis
The multidisciplinary team
- SMA Specialist: Dr Claudia Chiriboga, New York, NY, USA
- Neurologist: Dr James Wymer, Gainesville, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/
14 min - Personalized treatment of RET-altered thyroid cancers
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies//?_ga=2.65262702.1175448380.1654530922-407959475.165392596443 min - Personalized treatment of RET-altered thyroid cancers
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies/?_ga=2.29473663.1151443503.1654521477-1202917360.1651662103
43 min - Focus on cognitive impairment in the diagnosis and management of relapsing MS – Part 3
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives share their expert insights on the impact of cognitive dysfunction in relapsing MS, and how to best assess and manage the associated cognitive symptoms.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
- Neuropsychologist: Prof. Dawn Langdon, UK
- Advanced practice clinician: Ms Amy Perrin Ross, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms13 min - Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 2
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives discuss the current treatment landscape for relapsing MS and how oral DMTs can improve patient outcomes.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
- Advanced practice clinician: Ms Amy Perrin Ross, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms12 min - Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 1
touchMDT for touchNEUROLOGY
Listen to experts with multidisciplinary perspectives, discuss the importance of early diagnosis of relapsing MS for improved long-term patient outcomes.
The multidisciplinary team
- Neurologist/MS specialist: Prof. Mark Freedman, Canada
- Clinical psychologist/MS educator: Dr Rosalind Kalb, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms12 min
About touchPODCAST
From the publisher's feed
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.
Educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.